Bioventrix, Inc. funding
Bioventrix, Inc., a biotechnology company based in Mansfield, MA, filed a Form D with the SEC on October 8, 2026 and reported $1.2M raised of a $3M offering. It filed 2 new offerings in this period, totaling $1.9M.
Amount raised$1.2M
Offering size$3M
Filed with the SECOctober 8, 2026
First saleSeptember 29, 2026
IndustryBiotechnology
SecuritiesDebt, Options or warrants, Security to be acquired on exercise
LocationMansfield, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far6
Minimum investment$50K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 8
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| October 8, 2026 | $1.2M | $3M | Debt, Options or warrants, Security to be acquired on exercise |
| April 24, 2026 | $705K | $6M | Other |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care